img

Global Enramycin Premix Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture

Publisher : MRA | Format : PDF

Global Enramycin Premix Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Enramycin premix is formulated with enramycin, rice bran oil and corn flour. This product is a gray or gray-brown powder with a special odor. It is fermented by actinomycetes and is an unsaturated fatty acid. Polypeptide antibiotics combined with more than a dozen amino acids. It has a strong inhibitory effect on Gram-positive bacteria, and it is not easy to develop drug resistance after long-term use. It can change the distribution of bacterial communities in the intestinal tract, is conducive to the digestion and absorption of feed nutrients, promotes animal growth and improves feed conversion rate, so it is recommended as a pharmaceutical feed additive by many countries in the world. Enramycin is not easily absorbed, so there are fewer drug residues in the body of livestock and poultry.
Enramycin Premix report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Enramycin Premix market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Pig Fodder and Chicken Fodder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Enramycin Premix industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Enramycin Premix key manufacturers include Takeda, AdvaCare, Phiphar Healthcare, Boehringer Ingelheim, Eli Lilly and Company, Ravioza Biotech, Zhejiang Dayang Biology Technology, Bornsun Bioengineering and Shandong Shengli Bioengineering, etc. Takeda, AdvaCare, Phiphar Healthcare are top 3 players and held % sales share in total in 2022.
Enramycin Premix can be divided into Contains Enramycin 4% and Contains Enramycin 8%, etc. Contains Enramycin 4% is the mainstream product in the market, accounting for % sales share globally in 2022.
Enramycin Premix is widely used in various fields, such as Pig Fodder, Chicken Fodder and Others,, etc. Pig Fodder provides greatest supports to the Enramycin Premix industry development. In 2022, global % sales of Enramycin Premix went into Pig Fodder filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Enramycin Premix market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
Segment by Type
Contains Enramycin 4%
Contains Enramycin 8%

Segment by Application


Pig Fodder
Chicken Fodder
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Enramycin Premix market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Enramycin Premix, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Enramycin Premix industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of Enramycin Premix in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Enramycin Premix introduction, etc. Enramycin Premix Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of Enramycin Premix market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Enramycin Premix Market Overview
1.1 Enramycin Premix Product Overview
1.2 Enramycin Premix Market Segment by Type
1.2.1 Contains Enramycin 4%
1.2.2 Contains Enramycin 8%
1.3 Global Enramycin Premix Market Size by Type
1.3.1 Global Enramycin Premix Market Size Overview by Type (2018-2033)
1.3.2 Global Enramycin Premix Historic Market Size Review by Type (2018-2023)
1.3.3 Global Enramycin Premix Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.2 Europe Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Enramycin Premix Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Enramycin Premix Sales Breakdown by Type (2018-2023)
2 Global Enramycin Premix Market Competition by Company
2.1 Global Top Players by Enramycin Premix Sales (2018-2023)
2.2 Global Top Players by Enramycin Premix Revenue (2018-2023)
2.3 Global Top Players by Enramycin Premix Price (2018-2023)
2.4 Global Top Manufacturers Enramycin Premix Manufacturing Base Distribution, Sales Area, Product Type
2.5 Enramycin Premix Market Competitive Situation and Trends
2.5.1 Enramycin Premix Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Enramycin Premix Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enramycin Premix as of 2022)
2.7 Date of Key Manufacturers Enter into Enramycin Premix Market
2.8 Key Manufacturers Enramycin Premix Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Enramycin Premix Status and Outlook by Region
3.1 Global Enramycin Premix Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Enramycin Premix Historic Market Size by Region
3.2.1 Global Enramycin Premix Sales in Volume by Region (2018-2023)
3.2.2 Global Enramycin Premix Sales in Value by Region (2018-2023)
3.2.3 Global Enramycin Premix Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Enramycin Premix Forecasted Market Size by Region
3.3.1 Global Enramycin Premix Sales in Volume by Region (2024-2033)
3.3.2 Global Enramycin Premix Sales in Value by Region (2024-2033)
3.3.3 Global Enramycin Premix Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Enramycin Premix by Application
4.1 Enramycin Premix Market Segment by Application
4.1.1 Pig Fodder
4.1.2 Chicken Fodder
4.1.3 Others
4.2 Global Enramycin Premix Market Size by Application
4.2.1 Global Enramycin Premix Market Size Overview by Application (2018-2033)
4.2.2 Global Enramycin Premix Historic Market Size Review by Application (2018-2023)
4.2.3 Global Enramycin Premix Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.2 Europe Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Enramycin Premix Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Enramycin Premix Sales Breakdown by Application (2018-2023)
5 North America Enramycin Premix by Country
5.1 North America Enramycin Premix Historic Market Size by Country
5.1.1 North America Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Enramycin Premix Sales in Volume by Country (2018-2023)
5.1.3 North America Enramycin Premix Sales in Value by Country (2018-2023)
5.2 North America Enramycin Premix Forecasted Market Size by Country
5.2.1 North America Enramycin Premix Sales in Volume by Country (2024-2033)
5.2.2 North America Enramycin Premix Sales in Value by Country (2024-2033)
6 Europe Enramycin Premix by Country
6.1 Europe Enramycin Premix Historic Market Size by Country
6.1.1 Europe Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Enramycin Premix Sales in Volume by Country (2018-2023)
6.1.3 Europe Enramycin Premix Sales in Value by Country (2018-2023)
6.2 Europe Enramycin Premix Forecasted Market Size by Country
6.2.1 Europe Enramycin Premix Sales in Volume by Country (2024-2033)
6.2.2 Europe Enramycin Premix Sales in Value by Country (2024-2033)
7 Asia-Pacific Enramycin Premix by Region
7.1 Asia-Pacific Enramycin Premix Historic Market Size by Region
7.1.1 Asia-Pacific Enramycin Premix Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Enramycin Premix Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Enramycin Premix Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Enramycin Premix Forecasted Market Size by Region
7.2.1 Asia-Pacific Enramycin Premix Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Enramycin Premix Sales in Value by Region (2024-2033)
8 Latin America Enramycin Premix by Country
8.1 Latin America Enramycin Premix Historic Market Size by Country
8.1.1 Latin America Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Enramycin Premix Sales in Volume by Country (2018-2023)
8.1.3 Latin America Enramycin Premix Sales in Value by Country (2018-2023)
8.2 Latin America Enramycin Premix Forecasted Market Size by Country
8.2.1 Latin America Enramycin Premix Sales in Volume by Country (2024-2033)
8.2.2 Latin America Enramycin Premix Sales in Value by Country (2024-2033)
9 Middle East and Africa Enramycin Premix by Country
9.1 Middle East and Africa Enramycin Premix Historic Market Size by Country
9.1.1 Middle East and Africa Enramycin Premix Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Enramycin Premix Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Enramycin Premix Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Enramycin Premix Forecasted Market Size by Country
9.2.1 Middle East and Africa Enramycin Premix Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Enramycin Premix Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Enramycin Premix Products Offered
10.1.5 Takeda Recent Development
10.2 AdvaCare
10.2.1 AdvaCare Company Information
10.2.2 AdvaCare Introduction and Business Overview
10.2.3 AdvaCare Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AdvaCare Enramycin Premix Products Offered
10.2.5 AdvaCare Recent Development
10.3 Phiphar Healthcare
10.3.1 Phiphar Healthcare Company Information
10.3.2 Phiphar Healthcare Introduction and Business Overview
10.3.3 Phiphar Healthcare Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Phiphar Healthcare Enramycin Premix Products Offered
10.3.5 Phiphar Healthcare Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Information
10.4.2 Boehringer Ingelheim Introduction and Business Overview
10.4.3 Boehringer Ingelheim Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boehringer Ingelheim Enramycin Premix Products Offered
10.4.5 Boehringer Ingelheim Recent Development
10.5 Eli Lilly and Company
10.5.1 Eli Lilly and Company Company Information
10.5.2 Eli Lilly and Company Introduction and Business Overview
10.5.3 Eli Lilly and Company Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Eli Lilly and Company Enramycin Premix Products Offered
10.5.5 Eli Lilly and Company Recent Development
10.6 Ravioza Biotech
10.6.1 Ravioza Biotech Company Information
10.6.2 Ravioza Biotech Introduction and Business Overview
10.6.3 Ravioza Biotech Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Ravioza Biotech Enramycin Premix Products Offered
10.6.5 Ravioza Biotech Recent Development
10.7 Zhejiang Dayang Biology Technology
10.7.1 Zhejiang Dayang Biology Technology Company Information
10.7.2 Zhejiang Dayang Biology Technology Introduction and Business Overview
10.7.3 Zhejiang Dayang Biology Technology Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zhejiang Dayang Biology Technology Enramycin Premix Products Offered
10.7.5 Zhejiang Dayang Biology Technology Recent Development
10.8 Bornsun Bioengineering
10.8.1 Bornsun Bioengineering Company Information
10.8.2 Bornsun Bioengineering Introduction and Business Overview
10.8.3 Bornsun Bioengineering Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bornsun Bioengineering Enramycin Premix Products Offered
10.8.5 Bornsun Bioengineering Recent Development
10.9 Shandong Shengli Bioengineering
10.9.1 Shandong Shengli Bioengineering Company Information
10.9.2 Shandong Shengli Bioengineering Introduction and Business Overview
10.9.3 Shandong Shengli Bioengineering Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Shandong Shengli Bioengineering Enramycin Premix Products Offered
10.9.5 Shandong Shengli Bioengineering Recent Development
10.10 Apeloa Pharmaceutical
10.10.1 Apeloa Pharmaceutical Company Information
10.10.2 Apeloa Pharmaceutical Introduction and Business Overview
10.10.3 Apeloa Pharmaceutical Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Apeloa Pharmaceutical Enramycin Premix Products Offered
10.10.5 Apeloa Pharmaceutical Recent Development
10.11 Hvsen Biotechnology
10.11.1 Hvsen Biotechnology Company Information
10.11.2 Hvsen Biotechnology Introduction and Business Overview
10.11.3 Hvsen Biotechnology Enramycin Premix Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hvsen Biotechnology Enramycin Premix Products Offered
10.11.5 Hvsen Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Enramycin Premix Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Enramycin Premix Industrial Chain Analysis
11.4 Enramycin Premix Market Dynamics
11.4.1 Enramycin Premix Industry Trends
11.4.2 Enramycin Premix Market Drivers
11.4.3 Enramycin Premix Market Challenges
11.4.4 Enramycin Premix Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Enramycin Premix Distributors
12.3 Enramycin Premix Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Contains Enramycin 4%
Table 2. Major Company of Contains Enramycin 8%
Table 3. Global Enramycin Premix Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 5. Global Enramycin Premix Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Enramycin Premix Sales by Type (2018-2023) & (US& Million)
Table 7. Global Enramycin Premix Market Share in Value by Type (2018-2023)
Table 8. Global Enramycin Premix Price by Type (2018-2023) & (USD/MT)
Table 9. Global Enramycin Premix Sales by Type (2024-2033) & (K MT)
Table 10. Global Enramycin Premix Sales Market Share in Volume by Type (2024-2033)
Table 11. Global Enramycin Premix Sales by Type (2024-2033) & (US$ Million)
Table 12. Global Enramycin Premix Sales Market Share in Value by Type (2024-2033)
Table 13. Global Enramycin Premix Price by Type (2024-2033) & (USD/MT)
Table 14. North America Enramycin Premix Sales by Type (2018-2023) & (K MT)
Table 15. North America Enramycin Premix Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Enramycin Premix Sales (K MT) by Type (2018-2023)
Table 17. Europe Enramycin Premix Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Enramycin Premix Sales (K MT) by Type (2018-2023)
Table 19. Asia-Pacific Enramycin Premix Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Enramycin Premix Sales (K MT) by Type (2018-2023)
Table 21. Latin America Enramycin Premix Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Enramycin Premix Sales (K MT) by Type (2018-2023)
Table 23. Middle East and Africa Enramycin Premix Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Enramycin Premix Sales by Company (2018-2023) & (K MT)
Table 25. Global Enramycin Premix Sales Share by Company (2018-2023)
Table 26. Global Enramycin Premix Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Enramycin Premix Revenue Share by Company (2018-2023)
Table 28. Global Market Enramycin Premix Price by Company (2018-2023) & (USD/MT)
Table 29. Global Enramycin Premix Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Enramycin Premix Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Enramycin Premix as of 2022)
Table 32. Date of Key Manufacturers Enter into Enramycin Premix Market
Table 33. Key Manufacturers Enramycin Premix Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Enramycin Premix Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global Enramycin Premix Sales by Region (2018-2023) & (K MT)
Table 37. Global Enramycin Premix Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Enramycin Premix Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Enramycin Premix Sales Market Share in Value by Region (2018-2023)
Table 40. Global Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 41. Global Enramycin Premix Sales by Region (2024-2033) & (K MT)
Table 42. Global Enramycin Premix Sales Market Share in Volume by Region (2024-2033)
Table 43. Global Enramycin Premix Sales by Region (2024-2033) & (US$ Million)
Table 44. Global Enramycin Premix Sales Market Share in Value by Region (2024-2033)
Table 45. Global Enramycin Premix Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2033)
Table 46. Global Enramycin Premix Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global Enramycin Premix Sales by Application (2018-2023) & (K MT)
Table 48. Global Enramycin Premix Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Enramycin Premix Sales Market Share in Value by Application (2018-2023)
Table 51. Global Enramycin Premix Price by Application (2018-2023) & (USD/MT)
Table 52. Global Enramycin Premix Sales by Application (2024-2033) & (K MT)
Table 53. Global Enramycin Premix Sales Market Share in Volume by Application (2024-2033)
Table 54. Global Enramycin Premix Sales by Application (2024-2033) & (US$ Million)
Table 55. Global Enramycin Premix Sales Market Share in Value by Application (2024-2033)
Table 56. Global Enramycin Premix Price by Application (2024-2033) & (USD/MT)
Table 57. North America Enramycin Premix Sales by Application (2018-2023) (K MT)
Table 58. North America Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Enramycin Premix Sales by Application (2018-2023) (K MT)
Table 60. Europe Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Enramycin Premix Sales by Application (2018-2023) (K MT)
Table 62. Asia-Pacific Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Enramycin Premix Sales by Application (2018-2023) (K MT)
Table 64. Latin America Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Enramycin Premix Sales by Application (2018-2023) (K MT)
Table 66. Middle East and Africa Enramycin Premix Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 68. North America Enramycin Premix Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Enramycin Premix Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Enramycin Premix Sales Market Share in Value by Country (2018-2023)
Table 71. North America Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 72. North America Enramycin Premix Sales Market Share in Volume by Country (2024-2033)
Table 73. North America Enramycin Premix Sales by Country (2024-2033) & (US$ Million)
Table 74. North America Enramycin Premix Sales Market Share in Value by Country (2024-2033)
Table 75. Europe Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 76. Europe Enramycin Premix Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Enramycin Premix Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Enramycin Premix Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 80. Europe Enramycin Premix Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe Enramycin Premix Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe Enramycin Premix Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific Enramycin Premix Sales by Region (2018-2023) & (K MT)
Table 84. Asia-Pacific Enramycin Premix Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Enramycin Premix Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Enramycin Premix Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Enramycin Premix Sales by Region (2024-2033) & (K MT)
Table 88. Asia-Pacific Enramycin Premix Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific Enramycin Premix Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific Enramycin Premix Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 92. Latin America Enramycin Premix Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Enramycin Premix Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Enramycin Premix Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 96. Latin America Enramycin Premix Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America Enramycin Premix Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America Enramycin Premix Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa Enramycin Premix Sales by Country (2018-2023) & (K MT)
Table 100. Middle East and Africa Enramycin Premix Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Enramycin Premix Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Enramycin Premix Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Enramycin Premix Sales by Country (2024-2033) & (K MT)
Table 104. Middle East and Africa Enramycin Premix Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa Enramycin Premix Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa Enramycin Premix Sales Market Share in Value by Country (2024-2033)
Table 107. Takeda Company Information
Table 108. Takeda Introduction and Business Overview
Table 109. Takeda Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 110. Takeda Enramycin Premix Product
Table 111. Takeda Recent Development
Table 112. AdvaCare Company Information
Table 113. AdvaCare Introduction and Business Overview
Table 114. AdvaCare Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 115. AdvaCare Enramycin Premix Product
Table 116. AdvaCare Recent Development
Table 117. Phiphar Healthcare Company Information
Table 118. Phiphar Healthcare Introduction and Business Overview
Table 119. Phiphar Healthcare Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 120. Phiphar Healthcare Enramycin Premix Product
Table 121. Phiphar Healthcare Recent Development
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Introduction and Business Overview
Table 124. Boehringer Ingelheim Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 125. Boehringer Ingelheim Enramycin Premix Product
Table 126. Boehringer Ingelheim Recent Development
Table 127. Eli Lilly and Company Company Information
Table 128. Eli Lilly and Company Introduction and Business Overview
Table 129. Eli Lilly and Company Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 130. Eli Lilly and Company Enramycin Premix Product
Table 131. Eli Lilly and Company Recent Development
Table 132. Ravioza Biotech Company Information
Table 133. Ravioza Biotech Introduction and Business Overview
Table 134. Ravioza Biotech Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 135. Ravioza Biotech Enramycin Premix Product
Table 136. Ravioza Biotech Recent Development
Table 137. Zhejiang Dayang Biology Technology Company Information
Table 138. Zhejiang Dayang Biology Technology Introduction and Business Overview
Table 139. Zhejiang Dayang Biology Technology Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 140. Zhejiang Dayang Biology Technology Enramycin Premix Product
Table 141. Zhejiang Dayang Biology Technology Recent Development
Table 142. Bornsun Bioengineering Company Information
Table 143. Bornsun Bioengineering Introduction and Business Overview
Table 144. Bornsun Bioengineering Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 145. Bornsun Bioengineering Enramycin Premix Product
Table 146. Bornsun Bioengineering Recent Development
Table 147. Shandong Shengli Bioengineering Company Information
Table 148. Shandong Shengli Bioengineering Introduction and Business Overview
Table 149. Shandong Shengli Bioengineering Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 150. Shandong Shengli Bioengineering Enramycin Premix Product
Table 151. Shandong Shengli Bioengineering Recent Development
Table 152. Apeloa Pharmaceutical Company Information
Table 153. Apeloa Pharmaceutical Introduction and Business Overview
Table 154. Apeloa Pharmaceutical Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 155. Apeloa Pharmaceutical Enramycin Premix Product
Table 156. Apeloa Pharmaceutical Recent Development
Table 157. Hvsen Biotechnology Company Information
Table 158. Hvsen Biotechnology Introduction and Business Overview
Table 159. Hvsen Biotechnology Enramycin Premix Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 160. Hvsen Biotechnology Enramycin Premix Product
Table 161. Hvsen Biotechnology Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Enramycin Premix Market Trends
Table 165. Enramycin Premix Market Drivers
Table 166. Enramycin Premix Market Challenges
Table 167. Enramycin Premix Market Restraints
Table 168. Enramycin Premix Distributors List
Table 169. Enramycin Premix Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Enramycin Premix Product Picture
Figure 2. Global Enramycin Premix Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Enramycin Premix Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Enramycin Premix Sales Status and Outlook (2018-2033) & (K MT)
Figure 5. Product Picture of Contains Enramycin 4%
Figure 6. Global Contains Enramycin 4% Sales YoY Growth (2018-2033) & (K MT)
Figure 7. Product Picture of Contains Enramycin 8%
Figure 8. Global Contains Enramycin 8% Sales YoY Growth (2018-2033) & (K MT)
Figure 9. Global Enramycin Premix Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global Enramycin Premix Sales Market Share by Type in 2022 & 2033
Figure 11. North America Enramycin Premix Sales Market Share in Volume by Type in 2022
Figure 12. North America Enramycin Premix Sales Market Share in Value by Type in 2022
Figure 13. Europe Enramycin Premix Sales Market Share in Volume by Type in 2022
Figure 14. Europe Enramycin Premix Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Enramycin Premix Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Enramycin Premix Sales Market Share in Value by Type in 2022
Figure 17. Latin America Enramycin Premix Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Enramycin Premix Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Enramycin Premix Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Enramycin Premix Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Enramycin Premix Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Enramycin Premix Revenue in 2022
Figure 23. Enramycin Premix Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Pig Fodder
Figure 25. Global Pig Fodder Sales YoY Growth (2018-2033) & (K MT)
Figure 26. Product Picture of Chicken Fodder
Figure 27. Global Chicken Fodder Sales YoY Growth (2018-2033) & (K MT)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2033) & (K MT)
Figure 30. Global Enramycin Premix Sales by Application (2018-2033) & (US$ Million)
Figure 31. Global Enramycin Premix Sales Market Share by Application in 2022 & 2033
Figure 32. North America Enramycin Premix Sales Market Share in Volume by Application in 2022
Figure 33. North America Enramycin Premix Sales Market Share in Value by Application in 2022
Figure 34. Europe Enramycin Premix Sales Market Share in Volume by Application in 2022
Figure 35. Europe Enramycin Premix Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Enramycin Premix Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Enramycin Premix Sales Market Share in Value by Application in 2022
Figure 38. Latin America Enramycin Premix Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Enramycin Premix Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Enramycin Premix Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Enramycin Premix Manufacturing Cost Structure
Figure 43. Enramycin Premix Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries